Skip to content

Effect of Collagen Supplementation on Tendinopathy

Effect of Collagen Supplementation on Tendinopathy in Elite Athletes

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04578418
Enrollment
64
Registered
2020-10-08
Start date
2020-09-16
Completion date
2025-05-01
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy

Brief summary

Tendon injuries represent a significant problem in elite athletes. Therefore, prevention and effective treatment of tendon overload injury/tendinopathy is important. Among different treatment options, heavy-slow loading based rehabilitation is considered among the most efficient treatments in athletes. In this study, we will investigate if supplementation with hydrolyzed collagen in combination with a heavy-slow loading based 12 weeks rehabilitation regime can improve treatment of tendon overload injury/tendinopathy. The investigators will examine elite athletes with overload injury/tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography), and vascularization (Doppler US). The investigators hypothesize that collagen supplementation can have an improving effect on tendon pain and function. Thus, the investigation will show if a rehabilitation regime of collagen supplementation combined with heavy-slow mechanical loading can improve tendon healing compared to mechanical loading alone.

Detailed description

Randomized placebo-controlled intervention study with follow-up after one month

Interventions

DIETARY_SUPPLEMENTHydrolyzed collagen

Hydrolyzed collagen supplementation twice daily

Heavy slow resistance training 3 times weekly

DIETARY_SUPPLEMENTPlacebo

Placebo supplementation twice daily

Sponsors

Team Denmark
CollaboratorOTHER
University of Aarhus
CollaboratorOTHER
Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Elite athletes * 18-40 years old * Exercise related tendon pain on one or both legs * Soreness during physical examination of tendon upon palpation * Uni- or bilateral tendinopathy symptoms \> 3 months

Exclusion criteria

* Previous tendon surgery * Diabetes * Arthritis * Corticosteroid injection for tendinopathy within the last 3 months * Any form of tendon injection within the last 3 months * Smoking

Design outcomes

Primary

MeasureTime frameDescription
Maximal tendon pain during the past week at preferred sporting activityBaseline-12 weeksChange from baseline - 12 weeks using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)

Secondary

MeasureTime frameDescription
Self-reported activity level of sporting activities (hours/week)Baseline, 6 and 12 weeks + 6 month follow-upParticipants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity
Single-leg decline squat (SLDS) testBaseline - 12 weeksA reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Jump testBaseline - 12 weeksA reliable Achilles/Plantaris tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Treatment satisfaction12 weeksParticipants will be asked after the intervention period whether they were satisfied or not with the treatment (dichotomal : Yes vs. No)
Collagen supplementBaseline - 12 weeks + 6 month follow-upParticipants will be asked on a weekly basis if taken their collagen supplement : Questionnaire (dichotomal : Yes vs. No)
Adverse events (e.g. allergies, gastro-intestinal side effects) related to supplement ingestionBaseline - 12 weeks + 6 month follow-upParticipants will self-report adverse events during intervention period and at 6 month follow-up
Maximal tendon pain during the past week at preferred sporting activityBaseline, 6 weeks + 6 month follow-upChange from baseline - 6 weeks + 1 month follow-up using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Change from baseline Victorian Institute of Sports Assessment - Patella/Achilles Questionnaire (VISA-P/A) at 12 wksBaseline, 6 and 12 weeks + 6 month follow-upPatient reported outcome regarding symptoms, function and the ability to participate in sports
Change from baseline Foot function index - Plantaris questionnaire at 12 wksBaseline, 6 and 12 weeks + 6 month follow-upPatient reported outcome regarding symptoms, function and the ability to participate in sports
Tendon Doppler activity using Ultrasonography power DopplerBaseline - 12 weeksUsing Ultrasonography, we will measure Doppler activity within the affected tendon and use the program ImageJ for the analysis
Tendon thickness measured using UltrasonographyBaseline - 12 weeks
Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.Baseline, 6 and 12 weeks + 6 month follow-up
Return-to-sport activitiesBaseline - 12 weeks + 6 month follow-upParticipants will self-report Return-to-sport activities during intervention period and at 6 month follow-up (dichotomal : Yes vs. No)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026